← Back to Treatments
🏅 FDA Orphan Designation

Marqibo

vinCRIStine sulfate LIPOSOME injection

Manufacturer: Acrotech Biopharma LLC

Indicated for:
Acute lymphoblastic leukemiaOrphanPrecursor T-cell acute lymphoblastic leukemia

FDA-Approved Indications (2)

Treatment of adult patients with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more anti-leuke…

Treatment of adult patients with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more anti-leuke…

Population: adults

Indications & Usage

Treatment of adult patients with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more anti-leukemia therapies.

💙 Support Programs

View all →
Marqibo
Acrotech Biopharma LLC

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.